autologous ovarian cancer-specific cytotoxic T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-011732
A preparation of autologous cytotoxic T lymphocytes (CTLs) genetically modified to target a not yet disclosed ovarian cancer-specific tumor-associated antigen (TAA), with potential immunomodulating and antineoplastic activities. After isolation, transduction, expansion in culture, and reintroduction into the patient, the autologous ovarian cancer-specific cytotoxic T lymphocytes (OC-CTLs) bind to and induce selective toxicity in tumor cells expressing the TAA.
| Identifier | MLC-T-ONC-011732 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | OC-CTLs |
| Synonyms | autologous OC-CTLs; autologous ovarian cancer-specific CTLs |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011732",
"term": "autologous ovarian cancer-specific cytotoxic T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous cytotoxic T lymphocytes (CTLs) genetically modified to target a not yet disclosed ovarian cancer-specific tumor-associated antigen (TAA), with potential immunomodulating and antineoplastic activities. After isolation, transduction, expansion in culture, and reintroduction into the patient, the autologous ovarian cancer-specific cytotoxic T lymphocytes (OC-CTLs) bind to and induce selective toxicity in tumor cells expressing the TAA.",
"abbreviation": "OC-CTLs",
"synonyms": [
"autologous OC-CTLs",
"autologous ovarian cancer-specific CTLs"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-ovarian-cancer-specific-cytotoxic-t-lymphocytes/"
}
Record 3,068 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.